Financials
- Fiscal year
- 2025
- Total assets
- €1,101
- Loss
- -€3,895
- Solvency
- -4526.1%
Total assets▼ 5.0%
Net result
20192025
F.C.N.
ActiveSummary
The computed 12-month bankruptcy probability of F.C.N. is 1.6% (moderate). The 2025 annual accounts show negative equity (-€49,833) and a net result of -€3,895. Equity is shrinking by ~12% per year across the filed fiscal years. Its solvency ranks better than 5% of 8741 sector peers (fiscal year 2025). The company has been active since 2005 and the Belgian State Gazette contains no insolvency signals. The CBE does carry 1 administrative register entry (see administrative flags).
Overview
What they do
Wholesale of pharmaceutical and medical goods
NACE 46460NACE 51460
1 site
How big
€1,101total assets 2025
- Equity
- -€49,833
- Loss
- -€3,895
Turnover not published (abridged schema)
Who decides
Accounts filed 28 d late
Why 53- Loss of €3,895, the second in a row (FY 2025)- Latest accounts 28 days late; 2 of the last 3 late- Negative equity -€49,833+ Size: total assets €1,101Show the evidence
Checked score
Score 2025
53
/ 100
Fair
Probability in this band: 1.5% to 4.2%
Better than 11% of its sector peers (NACE 46, micro)
Performance against the sector, not lower risk
Financial strength · tick = 2024
Weak
Solvency
0=
equity -4526.1% of total assets
Liquidity
1-6
short-term debt 4626.1% · cash 1.0%
Profitability
0=
return on assets -353.7%
Bankruptcy probability, 12 months
1.6%
Moderate
0%0.5%1.5%4%10%≥ 25%
About 2 in 100 comparable companies go bankrupt within 12 months (an estimate).
- Size: total assets €1,101 lowers the probability for this profile
- Loss of €3,895, the second in a row (FY 2025) raises the probability
- Latest accounts 28 days late; 2 of the last 3 late raises the probability
- Negative equity -€49,833 raises the probability
No credit on open account
balance sheet total too small for a liquidity verdict, and equity is negative.
How it is calculated
The band comes from the bankruptcy probability on a scale of 0 to 100: every 10 points more double the odds of getting through the year without bankruptcy.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Place inside the band: half the bankruptcy probability, half how the company does against its sector peers (NACE 46, micro). Better than this share of them on solvency 6%, liquidity 4%, profitability 6%, growth against the median 27%. That is performance, not lower risk; the band itself always comes from the probability.
Bankruptcy probability: model pd-v3.202610021621, computed on 02-10-2026. The model learns from Belgian bankruptcies and reads the registers, the annual accounts and the gazette.
Ceilings: negative or zero equity, a heavy loss, a special KBO legal situation and a missing filing 59 (two missing 44), an ongoing judicial reorganisation or an ending 24. Financial strength does not count in the score.
Credit check for your own amount and term
Show the recommended maximum : and see how the verdict changes with amount, term and advance.
Signals
Seven signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
raises risk · Negative equity
The 2025 annual accounts show negative equity and a net loss.
NBB · annual accounts 2025Equity per financial year
19202122232425
2019 to 2025 · latest year -€49,833
neutral · Filed after the deadline
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 28-08-2026, 28 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 10 filingsDeviation from the deadline
2025
28 d late
2024
153 d late
2023
518 d late
2022
182 d late
2021
547 d late
2020
912 d late
2019
1277 d late
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
This company filed its last 7 accounts on average 517 days after the deadline; the sector median for financial year 2024 is 3 days before the deadline, and 39% of the sector filed late.
raises risk · Administrative warnings in the KBO publications
1 publication by the FPS Economy about this company, such as a strike-off for address, accounts or UBO, or its withdrawal.
KBO publicationsPublications
Strikeout withdrawn
Checked, nothing found (1)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. Usually files around 29 January (4 of the last 5 filed years within 337 days of that day).
Companies Code · seven monthsPosition in the running window
02-10-2026 today31-12-2026 close31-07-2027 deadline
- Annual accounts filedfiscal year 2025 · abbreviated…
- Annual accounts filedfiscal year 2024 · micro…
- Annual accounts filedfiscal year 2023 · micro…
Key points
By topic
Timeline
- Events
- 14
- Since
- 2015
- Next accounts
- by 31-07-2027
- 28-08-2026Annual accounts filed
- 31-12-2025Annual accounts filed
- 31-12-2025Annual accounts filed
Company details
- Sites
- 1
- Legal form
- Private limited company (pre-2019)
- Activity
- Wholesale of pharmaceutical and medical goodsNACE 46460
- Founded
- 24-10-2005
- Year ends
- 31-12
- Peppol
- Reachable for e-invoices
Go further with this company
How much credit can you give this customer, and on what term?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check How does this company compare with its sector?Sector benchmark What changed in the latest annual accounts?What changed
Your own company? See how customers, suppliers and banks see it and what to improve first.
Investigating this company? Keep it with today's facts in a case file.